ClinicalTrials.Veeva

Menu

INCMNSZ - Rheumatoid Arthritis Cohort (IRAC)

N

National Institute of Medical Sciences and Nutrition, Salvador Zubiran

Status

Unknown

Conditions

Early Rheumatoid Arthritis
Rheumatoid Arthritis

Treatments

Combination Product: DMARD´s and multidisciplinary treatment

Study type

Observational

Funder types

Other

Identifiers

NCT03389711
IRE-274-10/11-1

Details and patient eligibility

About

Identify Rheumatoid Arthritis patients diagnose within first 12 months since the beginning of the disease related symptoms. Initiate proper treatment according to international standards in order to achieve remission/low disease activity status.

Full description

  • Provide an standardized follow up by a multidisciplinary specialized team.
  • Create a biological (blood) bank to develop future research projects.
  • Create a database with the clinical, serologic, radiographic and functional status patients data.
  • Define comorbidities and mortality causes.
  • Begin an educational program to improve patient disease self-knowledge

Enrollment

237 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients ≥18 years old
  • Fulfilled ACR 1987 classification criteria for RA
  • Disease evolution of <1 year when first evaluated, and no specific rheumatic diagnosis except for RA.

Exclusion criteria

  • Patients with another rheumatic disease, except Sjögren syndrome.

Trial contacts and locations

1

Loading...

Central trial contact

Virginia Pascual, MD; Irazú Contreras, Msc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems